Ipamorelin 10 mg is a synthetic pentapeptide that acts as a selective agonist of growth hormone secretagogue receptor (GHS-R1a). It has been extensively studied in laboratory studies as a tool for understanding growth hormone (GH) regulation, ghrelin receptor pharmacology, hormonal signaling, and hypothalamus-pituitary axis biology. Unlike other GHRPs, Ipamorelin is highly selective for the receptor and has been shown in experimental investigations to increase secretion of GH without having much effect on other hormones of the anterior pituitary gland. (Raun et al., 1998; Cruz & Smit, 2008)
Ipamorelin is a synthetic pentapeptide that has been synthesized as an extremely selective activator of the GHS-R1a, also called the ghrelin receptor. The purpose of its synthesis is to study the physiological processes that underlie the regulation of growth hormone levels in the organism, but not to stimulate any other endocrine pathways that have been found in connection with some earlier GHRPs. Due to its selectivity for the GHS-R1a, Ipamorelin has become a useful tool for studies in laboratories. (Raun et al., 1998; Howard et al., 1996)
Ipamorelin acts through the selective interaction with the growth hormone secretagogue receptor (GHS-R1a), mainly located in the pituitary and hypothalamus. The binding of the receptor results in the development of intracellular signaling processes, which stimulate the natural secretion of growth hormone. Research shows that Ipamorelin is more selective in interacting with the receptors compared to some of the earlier generation GHRPs and usually causes no or low stimulation of ACTH, cortisol, or prolactin production relative to the less selective agonists. Thus, this peptide can be helpful for studying endocrine processes and the function of receptors. (Raun et al., 1998; Howard et al., 1996)
Ipamorelin has been commonly used for experimental purposes in the study of the physiology of growth hormone, signaling through ghrelin receptors, endocrinology, and pharmacology of peptides. Researchers utilize ipamorelin to study hypothalamus-pituitary interaction, the activation of growth hormone secretagogue receptors, signaling pathways, endocrine feedback systems, and hormone action on cells. This peptide has also been used as a model compound in the study of receptor selectivity and the biological effects of peptide agonists. These studies are aimed at gaining knowledge about endocrinology and peptide biology and should not be construed as medical uses. (Cruz & Smit, 2008; Müller et al., 2015)
The compound Ipamorelin has remained popular among researchers due to its ability to offer a good research model for studying selective activation of the GHS-R1a receptors and regulation of endogenous growth hormone. The selective action on the receptor sets it apart from previous compounds used as growth hormone secretagogues. Researchers can study the signaling pathway without affecting other hormones of the pituitary gland. This has contributed to research on the pharmacology of the receptors, the design of peptides, endocrine adaptation, and the physiology of the growth hormone axis. Despite the many studies conducted on the compound in laboratory settings and initial clinical studies, more research is needed. (Raun et al., 1998; Müller et al., 2015)
Product Name: Ipamorelin
Quantity: 10 mg
Peptide Type: Synthetic Pentapeptide
Research Category: Growth Hormone Secretagogue Receptor (GHS-R1a) Agonist
Appearance: White to slightly off-white lyophilized powder
Chemical Formula: C₃₈H₄₉N₉O₅
Molecular Mass: Approximately 711.85 g/mol
Purity: ≥98% (batch-specific analytical verification recommended
Grade: Research Grade
Intended Use: Laboratory Research Only
Accurate and dependable peptide research requires characterization of materials that are of defined identity and purity. Ipamorelin peptide in research grade will generally be produced according to known procedures of quality control and using analytical methods including HPLC and mass spectrometry to confirm the identity and purity of the peptides. The researcher should examine the COA documentation of the particular batch prior to using it in research.
In order to achieve stability for the peptide, Ipamorelin must be stored following the specifications set out by the manufacturer and laboratory protocols. The lyophilized peptide must be shielded from any extreme conditions such as heat, moisture, and light.
The ipamorelin 10 mg compound is meant to be used only in the context of laboratory experiments. It is meant to be utilized solely by trained scientists using well-equipped research laboratories. This chemical compound is not licensed for any human or animal application, nor is it intended for any therapeutic purpose in the treatment of any disease.
